.svg)
You've been taking fish oil and turmeric for months, and your joints still ache. The issue is usually form and dose: standard curcumin has under 1% bioavailability, and most fish oil capsules deliver too little EPA. Curcumin, omega-3s, and boswellia each target a different inflammatory pathway, but only specific formulations at tested doses produce measurable results. Here's what the science shows, and how to know if your supplements are actually working.
Superpower's Advanced Blood Panel tests the inflammatory markers, hs-CRP, ESR, and more, that reveal whether your supplement regimen is actually moving the needle on inflammation.
What Supplements Are Good for Inflammation
Inflammation is your immune system's response to injury, infection, or chronic stress. Acute inflammation resolves on its own. Chronic inflammation lingers, quietly driving conditions like arthritis, cardiovascular disease, and metabolic dysfunction. Anti-inflammatory supplements work by interrupting the specific molecular pathways that produce or sustain those signals.
Curcumin
Curcumin, the active compound in turmeric, inhibits NF-κB, a master regulator of inflammation that drives production of cytokines like TNF-α, IL-1β, and IL-6. It also blocks COX-2 and lipoxygenase enzymes, reducing prostaglandin production via the same enzymatic pathway.
The catch: standard curcumin has bioavailability below 1% in standard formulations. Without a delivery system, piperine, phytosome, or liposomal encapsulation, most of what you swallow passes through unabsorbed.
Omega-3 fatty acids
EPA and DHA from fish oil convert in the body into specialized pro-resolving mediators (SPMs), resolvins and protectins, that actively shut off inflammatory cascades rather than merely blocking them. This is a meaningful distinction: omega-3s don't just slow inflammation, they help resolve it.
Omega-3s also compete with omega-6 fatty acids for conversion into inflammatory eicosanoids. A higher omega-3 to omega-6 ratio shifts your body's signaling balance toward resolution, which explains why inflammatory markers tied to recovery may respond to consistent supplementation.
Boswellia
Boswellia serrata inhibits 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid into pro-inflammatory leukotrienes. Its most potent component, AKBA (3-O-acetyl-11-keto-β-boswellic acid), is responsible for most of this effect.
Unlike NSAIDs, boswellia doesn't inhibit prostaglandin synthesis via COX enzymes. That's likely why it has a more favorable gastrointestinal profile and why it's particularly well-studied for joint-related inflammation.
How These Supplements Affect Inflammatory Pathways
Effects on cytokine production
Omega-3 fatty acids at 1 to 3 grams of combined EPA and DHA per day consistently reduce CRP, TNF-α, and IL-6 in clinical trials. Research indicates boswellia extracts may lower inflammatory cytokines and reduce markers of cartilage degradation in osteoarthritis, with improvements in pain scores and physical function observed in clinical trials. Curcumin suppresses multiple cytokines simultaneously by targeting NF-κB upstream of many inflammatory cascades.
The gut-inflammation connection
Chronic inflammation often starts in the gut. A disrupted microbiome and compromised intestinal barrier allow bacterial endotoxins to enter circulation, triggering systemic inflammation. Omega-3s support gut barrier integrity and promote bacteria that produce short-chain fatty acids, which have anti-inflammatory effects. Curcumin modulates gut microbiota composition and reduces intestinal permeability, addressing one of the root drivers of whole-body inflammation. Tracking your gut microbiome balance alongside inflammatory markers gives you a clearer picture of what's actually driving your numbers.
Oxidative stress and inflammation
Inflammation and oxidative stress amplify each other. Preclinical studies show curcumin boosts endogenous antioxidant enzymes, superoxide dismutase and glutathione peroxidase, that neutralize the reactive oxygen species perpetuating inflammatory damage; human trial evidence for this specific mechanism remains limited. Omega-3s reduce lipid peroxidation, protecting cell membranes from oxidative injury. Boswellia's antioxidant effects complement its anti-inflammatory actions, particularly in joint tissue.
What Clinical Research Shows
Curcumin
A systematic review and meta-analysis of ten RCTs in rheumatoid arthritis (539 patients) found that curcumin supplementation produced significant improvements in disease activity scores (DAS28), ESR, CRP, and joint counts. A head-to-head open-label RCT (n=139) comparing curcumin and diclofenac in knee osteoarthritis found comparable reductions in pain scores in the curcumin group, with better gastrointestinal tolerability. These results, however, almost exclusively use enhanced-bioavailability formulations, phytosomes, piperine complexes, or liposomal delivery. Standard powder capsules without enhancement perform poorly.
Omega-3 fatty acids
An umbrella meta-analysis aggregating 32 prior meta-analyses found that omega-3 supplementation significantly reduced CRP, TNF-α, and IL-6 across diverse health conditions. Many trials targeting cardiovascular or metabolic inflammation used 3,000 mg or more of combined EPA and DHA daily for 3 to 12 months, though meaningful reductions in inflammatory markers have been observed at lower doses. Trials in this meta-analysis included people with cardiovascular disease, metabolic syndrome, and autoimmune conditions, with meaningful reductions in inflammatory markers observed across diverse study populations.
Boswellia
A systematic review and meta-analysis of seven RCTs (545 patients) found that boswellia supplementation for up to 6 months produced consistent reductions in pain, stiffness, and joint dysfunction in osteoarthritis. Dosing in these trials varies by extract type: standard extracts (standardized to 60–65% boswellic acids) are typically used at 600 to 900 mg daily, while AKBA-enriched extracts, such as 5-Loxin® (standardized to 30% AKBA), have demonstrated efficacy at lower doses of 100 to 250 mg in separate RCTs. The evidence is strongest for joint conditions, with emerging data suggesting broader anti-inflammatory applications, including other joint-related conditions.
Dosing, Form, and What to Look For
The doses below reflect ranges used in clinical research. Individual needs vary, consult a healthcare provider before starting any new supplement regimen, especially if you take medications or have an existing health condition.
Curcumin: form determines how much reaches your bloodstream
In a small pharmacokinetic study (n=10), piperine at 20 mg increased curcumin bioavailability by up to 2,000% in humans. Curcumin phytosomes, which bind curcumin to phosphatidylcholine, and micellar or liposomal formulations offer similar improvements. If your supplement doesn't specify one of these delivery systems, very little is reaching systemic circulation. Effective doses range from 500 mg to 2,000 mg per day depending on the formulation. Take curcumin with a fat-containing meal. A curcumin phytosome formulated specifically for absorption is a reliable place to start.
Omega-3s: dose and form
Triglyceride forms of omega-3s absorb better than ethyl ester forms. A crossover bioavailability study found re-esterified triglycerides absorbed with 24% greater efficiency than natural fish oil (a relative bioavailability index of 124%), while ethyl esters absorbed at only 73% relative to the natural triglyceride form. For anti-inflammatory effects, aim for 1 to 3 grams of combined EPA and DHA daily, higher doses for cardiovascular and metabolic conditions. EPA and DHA have complementary roles in inflammation resolution; a network meta-analysis of RCTs found similar effects of EPA and DHA on CRP, IL-6, and TNF-α, though EPA is the direct precursor to E-series resolvins and is the focus of most high-dose cardiovascular anti-inflammatory trials. Higher-EPA formulations remain the standard in anti-inflammatory protocols. High-EPA fish oil formulations or a vegetarian EPA/DHA option are both available. Take omega-3s with meals.
Boswellia: standardization is key
Not all boswellia products are equivalent. Look for extracts standardized to 60–65% boswellic acids, or specifically to AKBA, the compound responsible for 5-LOX inhibition. Doses of 600 to 900 mg are used in trials. Systematic review evidence supports a minimum treatment duration of 4 weeks to see measurable effects. Boswellia absorbs well with or without food. Look for a standardized boswellia extract that specifies AKBA content on the label.
Why Your Results May Vary
Not everyone responds equally to anti-inflammatory supplements. Several factors determine how much benefit you get:
- Baseline inflammation levels: People with higher CRP or ESR at baseline tend to see the largest reductions, there's more room for improvement.
- Gut health: Compromised intestinal permeability and dysbiosis reduce absorption of all three supplements. Address gut health alongside supplementation.
- Omega-3 status: People with low baseline omega-3 levels respond more dramatically to fish oil than those already eating oily fish regularly.
- Genetics: Cytochrome P450 enzyme variants affect how quickly your body metabolizes curcumin and omega-3s, influencing both efficacy and dosing needs.
- Concurrent medications: NSAIDs, corticosteroids, and anticoagulants can mask, interact with, or overlap with supplement effects.
- Supplement quality: Third-party tested products with verified potency and standardization consistently outperform generic formulations.
How to Track Whether Anti-Inflammatory Supplements Are Working
Subjective improvements in pain or energy are valuable. Biomarker data is better. Inflammation biomarker testing before you start supplementing and again after 8 to 12 weeks reveals whether your regimen is actually working, or whether you need to adjust the dose, switch formulations, or address other drivers like sleep or diet.
Key markers to track include:
- High-sensitivity C-reactive protein (hs-CRP), reflects systemic inflammation and cardiovascular risk. A drop from 5 mg/L to 2 mg/L after 12 weeks of curcumin and omega-3 supplementation is objective evidence of efficacy.
- Erythrocyte sedimentation rate (ESR), a general marker of inflammation, often elevated in autoimmune and chronic inflammatory conditions. The Advanced Blood Panel includes ESR alongside over 60 other biomarkers.
- Omega-3 index, measures EPA and DHA in red blood cell membranes, confirming whether fish oil supplementation is raising your tissue levels. An index above 8% is associated with reduced cardiovascular risk, a threshold established by Harris and von Schacky as the desirable zone for cardiovascular protection.
Trends over time matter more than any single value. If your CRP doesn't move after 12 weeks of consistent supplementation, that's data, telling you to adjust the approach, not simply take more of the same thing. If you have autoimmune-related joint inflammation, the Autoimmunity & Celiac Panel adds markers like rheumatoid factor and CCP antibodies to the picture.
What Supplements Are Good for Inflammation
Inflammation is your immune system's response to injury, infection, or chronic stress. Acute inflammation resolves on its own. Chronic inflammation lingers, quietly driving conditions like arthritis, cardiovascular disease, and metabolic dysfunction. Anti-inflammatory supplements work by interrupting the specific molecular pathways that produce or sustain those signals.
Curcumin
Curcumin, the active compound in turmeric, inhibits NF-κB, a master regulator of inflammation that drives production of cytokines like TNF-α, IL-1β, and IL-6. It also blocks COX-2 and lipoxygenase enzymes, reducing prostaglandin production via the same enzymatic pathway.
The catch: standard curcumin has bioavailability below 1% in standard formulations. Without a delivery system, piperine, phytosome, or liposomal encapsulation, most of what you swallow passes through unabsorbed.
Omega-3 fatty acids
EPA and DHA from fish oil convert in the body into specialized pro-resolving mediators (SPMs), resolvins and protectins, that actively shut off inflammatory cascades rather than merely blocking them. This is a meaningful distinction: omega-3s don't just slow inflammation, they help resolve it.
Omega-3s also compete with omega-6 fatty acids for conversion into inflammatory eicosanoids. A higher omega-3 to omega-6 ratio shifts your body's signaling balance toward resolution, which explains why inflammatory markers tied to recovery may respond to consistent supplementation.
Boswellia
Boswellia serrata inhibits 5-lipoxygenase (5-LOX), the enzyme that converts arachidonic acid into pro-inflammatory leukotrienes. Its most potent component, AKBA (3-O-acetyl-11-keto-β-boswellic acid), is responsible for most of this effect.
Unlike NSAIDs, boswellia doesn't inhibit prostaglandin synthesis via COX enzymes. That's likely why it has a more favorable gastrointestinal profile and why it's particularly well-studied for joint-related inflammation.
How These Supplements Affect Inflammatory Pathways
Effects on cytokine production
Omega-3 fatty acids at 1 to 3 grams of combined EPA and DHA per day consistently reduce CRP, TNF-α, and IL-6 in clinical trials. Research indicates boswellia extracts may lower inflammatory cytokines and reduce markers of cartilage degradation in osteoarthritis, with improvements in pain scores and physical function observed in clinical trials. Curcumin suppresses multiple cytokines simultaneously by targeting NF-κB upstream of many inflammatory cascades.
The gut-inflammation connection
Chronic inflammation often starts in the gut. A disrupted microbiome and compromised intestinal barrier allow bacterial endotoxins to enter circulation, triggering systemic inflammation. Omega-3s support gut barrier integrity and promote bacteria that produce short-chain fatty acids, which have anti-inflammatory effects. Curcumin modulates gut microbiota composition and reduces intestinal permeability, addressing one of the root drivers of whole-body inflammation. Tracking your gut microbiome balance alongside inflammatory markers gives you a clearer picture of what's actually driving your numbers.
Oxidative stress and inflammation
Inflammation and oxidative stress amplify each other. Preclinical studies show curcumin boosts endogenous antioxidant enzymes, superoxide dismutase and glutathione peroxidase, that neutralize the reactive oxygen species perpetuating inflammatory damage; human trial evidence for this specific mechanism remains limited. Omega-3s reduce lipid peroxidation, protecting cell membranes from oxidative injury. Boswellia's antioxidant effects complement its anti-inflammatory actions, particularly in joint tissue.
What Clinical Research Shows
Curcumin
A systematic review and meta-analysis of ten RCTs in rheumatoid arthritis (539 patients) found that curcumin supplementation produced significant improvements in disease activity scores (DAS28), ESR, CRP, and joint counts. A head-to-head open-label RCT (n=139) comparing curcumin and diclofenac in knee osteoarthritis found comparable reductions in pain scores in the curcumin group, with better gastrointestinal tolerability. These results, however, almost exclusively use enhanced-bioavailability formulations, phytosomes, piperine complexes, or liposomal delivery. Standard powder capsules without enhancement perform poorly.
Omega-3 fatty acids
An umbrella meta-analysis aggregating 32 prior meta-analyses found that omega-3 supplementation significantly reduced CRP, TNF-α, and IL-6 across diverse health conditions. Many trials targeting cardiovascular or metabolic inflammation used 3,000 mg or more of combined EPA and DHA daily for 3 to 12 months, though meaningful reductions in inflammatory markers have been observed at lower doses. Trials in this meta-analysis included people with cardiovascular disease, metabolic syndrome, and autoimmune conditions, with meaningful reductions in inflammatory markers observed across diverse study populations.
Boswellia
A systematic review and meta-analysis of seven RCTs (545 patients) found that boswellia supplementation for up to 6 months produced consistent reductions in pain, stiffness, and joint dysfunction in osteoarthritis. Dosing in these trials varies by extract type: standard extracts (standardized to 60–65% boswellic acids) are typically used at 600 to 900 mg daily, while AKBA-enriched extracts, such as 5-Loxin® (standardized to 30% AKBA), have demonstrated efficacy at lower doses of 100 to 250 mg in separate RCTs. The evidence is strongest for joint conditions, with emerging data suggesting broader anti-inflammatory applications, including other joint-related conditions.
Dosing, Form, and What to Look For
The doses below reflect ranges used in clinical research. Individual needs vary, consult a healthcare provider before starting any new supplement regimen, especially if you take medications or have an existing health condition.
Curcumin: form determines how much reaches your bloodstream
In a small pharmacokinetic study (n=10), piperine at 20 mg increased curcumin bioavailability by up to 2,000% in humans. Curcumin phytosomes, which bind curcumin to phosphatidylcholine, and micellar or liposomal formulations offer similar improvements. If your supplement doesn't specify one of these delivery systems, very little is reaching systemic circulation. Effective doses range from 500 mg to 2,000 mg per day depending on the formulation. Take curcumin with a fat-containing meal. A curcumin phytosome formulated specifically for absorption is a reliable place to start.
Omega-3s: dose and form
Triglyceride forms of omega-3s absorb better than ethyl ester forms. A crossover bioavailability study found re-esterified triglycerides absorbed with 24% greater efficiency than natural fish oil (a relative bioavailability index of 124%), while ethyl esters absorbed at only 73% relative to the natural triglyceride form. For anti-inflammatory effects, aim for 1 to 3 grams of combined EPA and DHA daily, higher doses for cardiovascular and metabolic conditions. EPA and DHA have complementary roles in inflammation resolution; a network meta-analysis of RCTs found similar effects of EPA and DHA on CRP, IL-6, and TNF-α, though EPA is the direct precursor to E-series resolvins and is the focus of most high-dose cardiovascular anti-inflammatory trials. Higher-EPA formulations remain the standard in anti-inflammatory protocols. High-EPA fish oil formulations or a vegetarian EPA/DHA option are both available. Take omega-3s with meals.
Boswellia: standardization is key
Not all boswellia products are equivalent. Look for extracts standardized to 60–65% boswellic acids, or specifically to AKBA, the compound responsible for 5-LOX inhibition. Doses of 600 to 900 mg are used in trials. Systematic review evidence supports a minimum treatment duration of 4 weeks to see measurable effects. Boswellia absorbs well with or without food. Look for a standardized boswellia extract that specifies AKBA content on the label.
Why Your Results May Vary
Not everyone responds equally to anti-inflammatory supplements. Several factors determine how much benefit you get:
- Baseline inflammation levels: People with higher CRP or ESR at baseline tend to see the largest reductions, there's more room for improvement.
- Gut health: Compromised intestinal permeability and dysbiosis reduce absorption of all three supplements. Address gut health alongside supplementation.
- Omega-3 status: People with low baseline omega-3 levels respond more dramatically to fish oil than those already eating oily fish regularly.
- Genetics: Cytochrome P450 enzyme variants affect how quickly your body metabolizes curcumin and omega-3s, influencing both efficacy and dosing needs.
- Concurrent medications: NSAIDs, corticosteroids, and anticoagulants can mask, interact with, or overlap with supplement effects.
- Supplement quality: Third-party tested products with verified potency and standardization consistently outperform generic formulations.
How to Track Whether Anti-Inflammatory Supplements Are Working
Subjective improvements in pain or energy are valuable. Biomarker data is better. Inflammation biomarker testing before you start supplementing and again after 8 to 12 weeks reveals whether your regimen is actually working, or whether you need to adjust the dose, switch formulations, or address other drivers like sleep or diet.
Key markers to track include:
- High-sensitivity C-reactive protein (hs-CRP), reflects systemic inflammation and cardiovascular risk. A drop from 5 mg/L to 2 mg/L after 12 weeks of curcumin and omega-3 supplementation is objective evidence of efficacy.
- Erythrocyte sedimentation rate (ESR), a general marker of inflammation, often elevated in autoimmune and chronic inflammatory conditions. The Advanced Blood Panel includes ESR alongside over 60 other biomarkers.
- Omega-3 index, measures EPA and DHA in red blood cell membranes, confirming whether fish oil supplementation is raising your tissue levels. An index above 8% is associated with reduced cardiovascular risk, a threshold established by Harris and von Schacky as the desirable zone for cardiovascular protection.
Trends over time matter more than any single value. If your CRP doesn't move after 12 weeks of consistent supplementation, that's data, telling you to adjust the approach, not simply take more of the same thing. If you have autoimmune-related joint inflammation, the Autoimmunity & Celiac Panel adds markers like rheumatoid factor and CCP antibodies to the picture.
.avif)